416 related articles for article (PubMed ID: 16730088)
21. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial.
Koukourakis MI; Bentzen SM; Giatromanolaki A; Wilson GD; Daley FM; Saunders MI; Dische S; Sivridis E; Harris AL
J Clin Oncol; 2006 Feb; 24(5):727-35. PubMed ID: 16418497
[TBL] [Abstract][Full Text] [Related]
22. Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial.
Janssens GO; Rademakers SE; Terhaard CH; Doornaert PA; Bijl HP; van den Ende P; Chin A; Marres HA; de Bree R; van der Kogel AJ; Hoogsteen IJ; Bussink J; Span PN; Kaanders JH
J Clin Oncol; 2012 May; 30(15):1777-83. PubMed ID: 22508814
[TBL] [Abstract][Full Text] [Related]
23. Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas.
Le QT; Kong C; Lavori PW; O'byrne K; Erler JT; Huang X; Chen Y; Cao H; Tibshirani R; Denko N; Giaccia AJ; Koong AC
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):167-75. PubMed ID: 17707270
[TBL] [Abstract][Full Text] [Related]
24. Carbonic anhydrase IX as a marker for poor prognosis in soft tissue sarcoma.
Måseide K; Kandel RA; Bell RS; Catton CN; O'Sullivan B; Wunder JS; Pintilie M; Hedley D; Hill RP
Clin Cancer Res; 2004 Jul; 10(13):4464-71. PubMed ID: 15240538
[TBL] [Abstract][Full Text] [Related]
25. Expression of CA-IX is associated with advanced stage tumors and poor survival in oral squamous cell carcinoma patients.
Pérez-Sayáns M; Suárez-Peñaranda JM; Pilar GD; Supuran CT; Pastorekova S; Barros-Angueira F; Gándara-Rey JM; García-García A
J Oral Pathol Med; 2012 Oct; 41(9):667-74. PubMed ID: 22486898
[TBL] [Abstract][Full Text] [Related]
26. [Relation between carbonic anhydrase IX serum level, hypoxia and radiation resistance of head and neck cancers].
Rosenberg V; Pastoreková S; Zaťovičová M; Slezák P; Waczulíková I; Svec J
Klin Onkol; 2014; 27(4):269-75. PubMed ID: 25115716
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinoma.
Bernstein JM; Andrews TD; Slevin NJ; West CM; Homer JJ
Laryngoscope; 2015 Jan; 125(1):E8-15. PubMed ID: 25230150
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.
Chia SK; Wykoff CC; Watson PH; Han C; Leek RD; Pastorek J; Gatter KC; Ratcliffe P; Harris AL
J Clin Oncol; 2001 Aug; 19(16):3660-8. PubMed ID: 11504747
[TBL] [Abstract][Full Text] [Related]
29. The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis.
Colpaert CG; Vermeulen PB; Fox SB; Harris AL; Dirix LY; Van Marck EA
Breast Cancer Res Treat; 2003 Sep; 81(2):137-47. PubMed ID: 14572156
[TBL] [Abstract][Full Text] [Related]
30. Use of multiple biological markers in radiotherapy-treated head and neck cancer.
Silva P; Slevin NJ; Sloan P; Valentine H; Ryder D; Price P; West CM; Homer JJ
J Laryngol Otol; 2010 Jun; 124(6):650-8. PubMed ID: 20388242
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia.
Hoogsteen IJ; Lok J; Marres HA; Takes RP; Rijken PF; van der Kogel AJ; Kaanders JH
Eur J Cancer; 2009 Nov; 45(16):2906-14. PubMed ID: 19699082
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy.
Ou D; Garberis I; Adam J; Blanchard P; Nguyen F; Levy A; Casiraghi O; Gorphe P; Breuskin I; Janot F; Temam S; Scoazec JY; Deutsch E; Tao Y
Radiother Oncol; 2018 Jan; 126(1):116-124. PubMed ID: 29079308
[TBL] [Abstract][Full Text] [Related]
33. Expression of endogenous hypoxia markers in vulvar squamous cell carcinoma.
Li YZ; Li SL; Li X; Wang LJ; Wang JL; Xu JW; Wu ZH; Gong L; Zhang XD
Asian Pac J Cancer Prev; 2012; 13(8):3675-80. PubMed ID: 23098453
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia, metabolism, and growth factor signaling in head and neck squamous cell carcinoma: correlation between primary and xenograft tumors.
Stegeman H; Rademakers SE; Span PN; Takes RP; van der Kogel AJ; Kaanders JH; Bussink J
Head Neck; 2014 Sep; 36(9):1288-95. PubMed ID: 24668936
[TBL] [Abstract][Full Text] [Related]
35. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
Vordermark D; Brown JM
Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
[TBL] [Abstract][Full Text] [Related]
36. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix.
Loncaster JA; Harris AL; Davidson SE; Logue JP; Hunter RD; Wycoff CC; Pastorek J; Ratcliffe PJ; Stratford IJ; West CM
Cancer Res; 2001 Sep; 61(17):6394-9. PubMed ID: 11522632
[TBL] [Abstract][Full Text] [Related]
37. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
[TBL] [Abstract][Full Text] [Related]
38. Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.
Rademakers SE; Lok J; van der Kogel AJ; Bussink J; Kaanders JH
BMC Cancer; 2011 May; 11():167. PubMed ID: 21569415
[TBL] [Abstract][Full Text] [Related]
39. High serum carbonic anhydrase IX predicts shorter survival in head and neck cancer.
Rosenberg V; Pastorekova S; Zatovicova M; Vidlickova I; Jelenska L; Slezak P
Bratisl Lek Listy; 2016; 117(4):201-4. PubMed ID: 27075382
[TBL] [Abstract][Full Text] [Related]
40. No detectable hypoxia in malignant salivary gland tumors: preliminary results.
Wijffels KI; Hoogsteen IJ; Lok J; Rijken PF; Marres HA; de Wilde PC; van der Kogel AJ; Kaanders JH
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1319-25. PubMed ID: 18973979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
